How much does a box of Belumosudil cost on the market?

Belumosudil mesylate tablets (Belumosudil) is a new type of small molecule oral drug that has gradually attracted attention in the treatment of chronic graft-versus-host disease (cGvHD) and other immune-related diseases in recent years. The drug has been approved for marketing in China and has been included in the medical insurance reimbursement system. The commonly used specification is 0.2g*30 tablets, and each box sells for about 10,000 to 20,000 yuan. Although the price is higher, it is still relatively accessible compared to overseas original research versions.

In overseas markets, the original drug Besudil is more expensive, with each box selling for more than US$10,000. This is mainly affected by R&D costs and the international market pricing mechanism. In addition, some generic versions have been launched overseas. For example, Besudil of the same specification produced by Lucius Pharmaceutical Factory in Laos is priced at about 4,000 yuan per box, but the price may change due to exchange rate fluctuations.

The market price of Besudil reflects its special value in the treatment of chronic immune rejection. Compared with traditional immunosuppressants, this drug has the advantages of oral administration, long-term maintenance of stable blood concentration, and less impact on patients' quality of life. This also makes it gradually become the choice for refractory cases in patients with chronic GvHD. Although the price is higher, patients can get some relief from their financial burden after being included in medical insurance.

When actually purchasing drugs, patients should give priority to obtaining Besudil through regular domestic hospitals or pharmacies to ensure drug quality and safety. Drug prices in overseas markets vary greatly, especially between original drugs and generic drugs. Purchasing through formal channels not only ensures the effectiveness of the drug, but also allows the dosage to be adjusted reasonably under the guidance of a doctor to improve the therapeutic effect.

Overall, although besudil is more expensive, combined with its unique mechanism of action and therapeutic value, it is an option worth considering for patients who need long-term management of immune rejection.

Reference: https://www.drugs.com/pro/rezurock.html